Biotech company Vaxxas, which is currently building its manufacturing facility in Northshore Hamilton, received the “Accenture Australia Award for Product Innovation” at the 2022 Lord Mayor’s Business Awards.
Read: Works Progressing Well For Northshore’s Needle-free Vaccine Facility
Vaxxas took home the recognition for their needle-free vaccine, which is delivered through high-density microarray patch. The squared patch has around 5,000 little projections invisible to the naked eye and is said to be less invasive than a shot.
In July 2022, the company has already completed preclinical animal studies, which suggests the patches’ efficacy against all currently known variants of Covid-19.
The technology, which is attracting global attention from leading health, philanthropic and government organisations, has a number of benefits, including enhanced immune response, eliminating the need for deep refrigeration, low-skilled or self-administration, and reduced patient anxiety.
The company announced the initiation of Phase 1 clinical study of their first needle-free vaccine In November 2022. It’s being conducted at the University of the Sunshine Coast’s Sippy Downs clinical research location.
If the studies are successful, Vaxxas would make the vaccine patches available to the market as early as 2025.
Vaxxas will manufacture their Phase II, Phase III and early-stage commercial use in Hamilton, a first of its kind in Australia featuring a house office, R&D laboratories, and device and cleanroom manufacturing spaces.
2022 Lord Mayor’s Business Awards
The Lord Mayor’s Business Awards recognise the best and most innovative businesses and entrepreneurs in Brisbane. The awards centre on the energy, drive and passion behind businesses in any commercial or industrial sector contributing to the growth of Brisbane’s economy.
Around 600 business leaders participated at the 2022 Lord Mayor’s Business Awards. For this year, winners were announced at a gala dinner in City Hall on 21 October 2022.
Read: Portside Wharf Set for Major Transformation
The Accenture Australia Award for Product Innovation is one of the nine categories open to businesses. Vaxxas topped other three finalists for the category –software company RedEye Apps, Morningside based outlet mall Circonomy, and Li-S Energy, which makes lightweight lithium sulfur batteries.